The inflammatory response to cell death

Annual Review of Pathology: Mechanisms of Disease

Volumn 3, Issue , 2008, Pages 99-126

  Rock, Kenneth L ^a   Kono, Hajime ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Danger; Inflammation; Necrosis; Toll like receptors

Indexed keywords

ADAPTOR PROTEIN; ANTIGEN; CELL RECEPTOR; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; FIBRINOGEN; GALECTIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEAR PROTEIN; PLASMA PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; VASCULAR ADHESION PROTEIN 1;

APOPTOSIS; BLOOD VESSEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; COMPLEMENT SYSTEM; DENDRITIC CELL; EXTRACELLULAR MATRIX; HOST RESISTANCE; HUMAN; HYPEREMIA; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; MOLECULAR BIOLOGY; NECROSIS; NEUTROPHIL; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TISSUE INJURY; TISSUE REPAIR;

ACUTE DISEASE; APOPTOSIS; CHEMOKINES; HUMANS; INFLAMMATION; NECROSIS;

EID: 41749104586     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathmechdis.3.121806.151456     Document Type: Review

References (160)

1. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, et al. 2000. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6:151-58
2. Kaplan AP, Joseph K, Silverberg M. 2002. Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109:195-209
3. Klinger MH. 1997. Platelets and inflammation. Anat. Embryol. 196:1-11
4. Page AR, Good RA. 1958. A clinical and experimental study of the function of neutrophils in the inflammatory response. Am. J. Pathol. 34:645-69
5. Majno G, La Gattuta M, Thompson TE. 1960. Cellular death and necrosis: chemical, physical and morphologic changes in rat liver. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 333:421-65
6. Boxer L, Dale DC. 2002. Neutropenia: causes and consequences. Semin. Hematol. 39:75-81
7. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045
8. Dunn GP, Koebel CM, Schreiber RD. 2006. Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6:836-48
9. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146:3-15
10. Huynh ML, Fadok VA, Henson PM. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41-50
11. Chung EY, Kim SJ, Ma XJ. 2006. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res. 16:154-61
12. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-65
13. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, et al. 2001. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-KB-independent, caspase-3-dependent pathway. J. Biol. Chem. 276:49077-82
14. Fujimoto I, Pan J, Takizawa T, Nakanishi Y. 2000. Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages. J. Virol. 74:3399-403
15. Takeda K, Akira S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14
16. Inohara C, McDonald C, Nunez G. 2005. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74:355-83
17. Robinson MJ, Sancho D, Slack EC, Leibundgut-Landmann S, Sousa CR. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7:1258-65
18. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-37
19. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511
20. Baeuerle PA, Henkel T. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-79
21. Kohl J. 2006. The role of complement in danger sensing and transmission. Immunol. Res. 34:157-76
22. Volanakis JE. 1990. Participation of C3 and its ligands in complement activation. Curr. Top. Microbiol. Immunol. 153:1-21
23. Gadjeva M, Takahashi K, Thiel S. 2004. Mannan-binding lectin-a soluble pattern recognition molecule. Mol. Immunol. 41:113-21
24. Cooper NR. 1985. The classical complement pathway: Activation and regulation of the first complement component. Adv. Immunol. 37:151-216
25. Ehlers MR. 2000. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2:289-94
26. Esser AF. 1991. Big MAC attack: Complement proteins cause leaky patches. Immunol. Today 12:316-18
27. Gerard C, Gerard NP. 1994. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775-808
28. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. 2007. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13:851-56
29. Mariathasan S, Monack DM. 2007. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7:31-40
30. Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-42
31. Landsman D, Bustin M. 1993. A signature for the HMG-1 box DNA-binding proteins. BioEssays 15:539-46
32. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-95
33. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, et al. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201:1135-43
34. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, et al. 2005. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ. Res. 97:e73-83
35. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, et al. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBORep. 3:995-1001
36. Yang H, Wang H, Czura CJ, Tracey KJ. 2005. The cytokine activity of HMGB1. J. Leukoc. Biol. 78:1-8
37. Li J, Wang H, Mason JM, Levine J, Yu M, et al. 2004. Recombinant HMGB1 with cytokine-stimulating activity. J. Immunol. Methods 289:211-23
38. Zimmermann K, Volkel D, Pable S, Lindner T, Kramberger F, et al. 2004. Native versus recombinant high-mobility group B1 proteins: Functional activity in vitro. Inflammation 28:221-29
39. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. 2007. Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J. Leukoc. Biol. 81:49-58
40. Shi Y, Evans JE, Rock KL. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-21
41. Terkeltaub R. 2005. Pathogenesis and treatment of crystal-induced inflammation. In Arthritis and Allied Conditions, ed. WKoopman, LW Moreland, pp. 23-57. Philadelphia: Lippincott Williams & Wilkins
42. Gordon TP, Kowanko IC, James M, Roberts-Thomson PJ. 1985. Monosodium urate crystal-induced prostaglandin synthesis in the rat subcutaneous air pouch. Clin. Exp. Rheumatol. 3:291-96
43. Liu FT, Rabinovich GA. 2005. Galectins as modulators of tumour progression. Nat. Rev. Cancer 5:29-41
44. Almkvist J, Karlsson A. 2004. Galectins as inflammatory mediators. Glycoconj. J. 19:575-81
45. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, et al. 2000. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165:2156-64
46. Schenk H, Vogt M, Droge W, Schulze-Osthoff K. 1996. Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 156:765-71
47. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, et al. 1999. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 189:1783-89
48. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901
49. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. 2003. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil Chemotaxis and adhesion. J. Immunol. 170:3233-42
50. Foell D, Wittkowski H, Vogl T, Roth J. 2007. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81:28-37
51. Hefeneider SH, Cornell KA, Brown LE, Bakke AC, McCoy SL, et al. 1992. Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin. Immunol. Immunopathol. 63:245-51
52. Tsan MF, Gao B. 2004. Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 286:C739-44
53. Wallin RP, Lundqvist A, More SH, von Bonin A, Kiessling R, et al. 2002. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23:130-35
54. Bausinger H, Lipsker D, Ziylan U, Manie S, Briand JP, et al. 2002. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32:3708-13
55. Zanetti M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48
56. Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174:6257-65
57. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, et al. 1999. β-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-28
58. Carp H. 1982. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155:264-75
59. Gawlowski DM, Benoit JN, Granger HJ. 1993. Microvascular pressure and albumin extravasation after leukocyte activation in hamster cheek pouch. Am. J. Physiol. Heart Circ. Physiol. 264:H541-46
60. Hill JH, Ward PA. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133:885-900
61. Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, et al. 1975. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J. Clin. Invest. 56:740-50
62. Weisman HF, Bartow T, Leppo MK, Marsh HCJ, Carson GR, et al. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146-51
63. Pinckard RN, Olson MS, Kelley RE, DeHeer DH, Palmer JD, et al. 1973. Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J. Immunol. 110:1376-82
64. Carroll MC, Holers VM. 2005. Innate autoimmunity. Adv. Immunol. 86:137-57
65. Zhang M, Alicot EM, Chiu I, Li J, Verna N, et al. 2006. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203:141-52
66. Weiser MR, Williams JP, Moore FD Jr, Kobzil L, Ma M, et al. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:2343-48
67. Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, et al. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101:3886-91
68. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, et al. 2004. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279:17079-84
69. Wrenshall LE, Cerra FB, Carlson A, Bach FH, Platt JL. 1991. Regulation of murine splenocyte responses by heparan sulfate. J. Immunol. 147:455-59
70. Wrenshall LE, Stevens RB, Cerra FB, Platt JL. 1999. Modulation of macrophage and B cell function by glycosaminoglycans. J. Leukoc. Biol. 66:391-400
71. Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Piatt JL. 2000. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J. Immunol. 165:1599-604
72. Postlethwaite AE, Kang AH. 1976. Collagen-and collagen peptide-induced Chemotaxis of human blood monocytes. J. Exp. Med. 143:1299-307
73. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, et al. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12:317-23
74. Chang C, Houck JC. 1970. Demonstration of the chemotactic properties of collagen. Proc. Soc. Exp. Biol. Med. 134:22-26
75. Postlethwaite AE, Keski-Oja J, Balian G, Kang AH. 1981. Induction of fibroblast Chemotaxis by fibroneetin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J. Exp. Med. 153:494-99
76. Tsukamoto Y, Helsel WE, Wahl SM. 1981. Macrophage production of fibroneetin, a chemoattractant for fibroblasts. J. Immunol. 127:673-78
77. Bowersox JC, Sorgente N. 1982. Chemotaxis of aortic endothelial cells in response to fibroneetin. Cancer Res 42:2547-51
78. Norris DA, Clark RA, Swigart LM, Huff JC, Weston WL, et al. 1982. Fibronectin fragments) are chemotactic for human peripheral blood monocytes. J. Immunol. 129:1612-18
79. Senior RM, Griffin GL, Mecham RP. 1980. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66:859-62
80. Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, et al. 1984. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J. Cell Biol. 99:870-74
81. Kamoun A, Landeau JM, Godeau G, Wallach J, Duchesnay A, et al. 1995. Growth stimulation of human skin fibroblasts by elastin-derived peptides. Cell Adhes. Commun. 3:273-81
82. Kaplan AP, Joseph K, Shibayama Y, Reddigari S, Ghebrehiwet B, et al. 1997. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv. Immunol. 66:225-72
83. Hori O, Brett J, Slattery T, Cao R, Zhang J, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270:25752-61
84. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, et al. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279:7370-77
85. Ohashi K, Burkart V, Flohe S, Kolb H. 2000. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:558-61
86. Smiley ST, King JA, Hancock WW. 2001. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167:2887-94
87. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, et al. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:99-111
88. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J. Immunol. 168:5233-39
89. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, et al. 2001. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:31332-39
90. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, et al. 2006. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177:1272-81
91. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, et al. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 416:603-7
92. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. 2005. Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 52:2936-46
93. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, et al. 2006. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116:2262-71
94. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-41
95. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, et al. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-32
96. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, et al. 1999. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354:1932-39
97. Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, et al. 2005. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 52:818-25
98. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, et al. 1983. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67:1016-23
99. Liu ZX, Han D, Gunawan B, Kaplowitz N. 2006. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43:1220-30
100. Martin P, Leibovich SJ. 2005. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 15:599-607
101. Fleischmann R, Stern R, Iqbal I. 2004. Anakinra: An inhibitor of IL-1 for the treatment of rheumatoid arthritis. Expert Opin. Biol. Ther. 4:1333-44
102. Germain RN. 1994. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287-99
103. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-52
104. Schwartz RH. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349-56
105. Sharpe AH, Freeman GJ. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-26
106. Brightbill HD, Library DH, Krutzik SR, Yang RB, Belisle JT, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-36
107. Gallucci S, Lolkema M, Matzinger P. 1999. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5:1249-55
108. Shi Y, Zheng W, Rock KL. 2000. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 97:14590-95
109. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, et al. 2004. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5:825-30
110. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, et al. 1998. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4:581-87
111. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, et al. 2002. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298:1025-29
112. Shi Y, Galusha SA, Rock KL. 2006. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176:3905-8
113. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. 2003. Physiological β cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198:1527-37
114. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, et al. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce Chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1197-206
115. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, et al. 2000. HMG-1 stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565-70
116. Messmer D, Yang H, Telusma G, Knoll F, Li J, et al. 2004. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173:307-13
117. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, et al. 2007. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res. 100:204-12
118. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-51
119. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, et al. 2004. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am. J. Respir. Crit. Care Med. 170:1310-16
120. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, et al. 2003. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48:2052-58
121. Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. 2006. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J. Immunol. 177:6370-78
122. Decker P, Singh-Jasuja H, Haager S, Kotter I, Rammensee HG. 2005. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J. Immunol. 174:3326-34
123. Ronnefarth VM, Erbacher AI, Lamkemeyer T, Madlung J, Nordheim A, et al. 2006. TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. J. Immunol. 177:7740-49
124. Deleted in proof
125. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, et al. 2001. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167:2602-7
126. Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, et al. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199:1631-40
127. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12:1539-46
128. Panjwani NN, Popova L, Srivastava PK. 2002. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168:2997-3003
129. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, et al. 2000. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6:435-42
130. Basu S, Binder RJ, Ramalingam T, Srivastava PK. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-13
131. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, et al. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353-62
132. Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. 1999. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 162:3212-19
133. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. 2000. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164:13-17
134. Binder RJ, Anderson KM, Basu S, Srivastava PK. 2000. Cutting edge: Heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J. Immunol. 165:6029-35
135. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, et al. 2002. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277:20847-53
136. Berwin B, Delneste Y, Lovingood RV, Post SR, Pizzo SV. 2004. SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin. J. Biol. Chem. 279:51250-57
137. Berwin B, Hart JP, Rice S, Gass C, Pizzo SV, et al. 2003. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 22:6127-36
138. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, et al. 1994. Galectins: a family of animal β-galactoside-binding lectins. Cell 76:597-98
139. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, et al. 2005. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 175:2974-81
140. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, et al. 2000. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275:40096-105
141. Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M. 1990. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote Chemotaxis and inhibit O2 generation, respectively. J. Clin. Invest. 85:1150-57
142. Burnstock G, Knight GE. 2004. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240:31-304
143. Fu H, Karlsson J, Bylund J, Movitz C, Karlsson A, Dahlgren C. 2006. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79:247-56
144. Weber C, Springer TA. 1997. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to αIIbβ3 and stimulated by platelet-activating factor. J. Clin. Invest. 100:2085-93
145. Fan ST, Edgington TS. 1993. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-α responses of monocytes. J. Immunol. 150:2972-80
146. Pfister RR, Haddox JL, Sommers CI. 1998. Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury. Invest. Ophthalmol. Vis. Sci. 39:1744-50
147. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, et al. 2006. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest. 116:753-59
148. Loftus JC, Smith JW, Ginsberg MH. 1994. Integrin-mediated cell adhesion: the extracellular face. J. Biol. Chem. 269:25235-38
149. Kobayashi H, Terao T. 1997. Hyaluronic acid-specific regulation of cytokines by human uterine fibroblasts. Am. J. Physiol. Cell Physiol. 273:0151-59
150. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, et al. 2000. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165:1863-70
151. Jiang D, Liang J, Fan J, Yu S, Chen S, et al. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11:1173-79
152. Adair-Kirk TL, Atkinson JJ, Broekelmann TJ, Doi M, Tryggvason K, et al. 2003. A site on laminin α 5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and Chemotaxis. J. Immunol. 171:398-406
153. Orlova W, Choi EY, Xie C, Chavakis E, Bierhaus A, et al. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26:1129-39
154. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, et al. 2004. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172:1146-56
155. Lillard JW Jr, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR. 1999. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. USA 96:651-56
156. Poelstra K, Heynen ER, Baller JF, Hardonk MJ, Bakker WW. 1992. Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides. Evidence for an anti-inflammatory role for nucleotidases. Lab. Invest. 66:555-63
157. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13:913-19
158. la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. 2001. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate ThI responses. J. Immunol. 166:1611-17
159. Tobiasova-Czetoova Z, Palmborg A, Lundqvist A, Karlsson G, Adamson L, et al. 2005. Effects of human plasma proteins on maturation of monocyte-derived dendritic cells. Immunol. Lett. 100:113-19
160. Mahnke K, Bhardwaj RS, Luger TA, Schwarz T, Grabbe S. 1996. Interaction of murine dendritic cells with collagen up-regulates allostimulatory capacity, surface expression of heat stable antigen, and release of cytokines. J. Leukoc. Biol. 60:465-72